EC Healthcare (HKG:2138) Full Year 2024 Results
Key Financial Results
- Revenue: HK$4.22b (up 8.9% from FY 2023).
- Net loss: HK$18.9m (down by 127% from HK$69.7m profit in FY 2023).
- HK$0.016 loss per share (down from HK$0.059 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
EC Healthcare Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) was also behind analyst expectations.
Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Consumer Services industry in Hong Kong.
Performance of the Hong Kong Consumer Services industry.
The company's shares are down 4.0% from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for EC Healthcare that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com